HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peplomycin induces G1-phase specific apoptosis in liver carcinoma cell line Bel-7402 involving G2-phase arrest.

AbstractAIM:
To investigate the mechanism of peplomycin (PEP)-induced apoptosis in liver carcinoma cell line (Bel-7402).
METHODS:
Growth inhibition by PEP was analyzed using 3- 4,5-Dimethylthiazol-2-yl-2,5-diphenyltetrazolium bromide (MTT) assay. Apoptotic cells were detected using Hoechest 33258 staining, and confirmed by flow cytometric analysis and DNA fragmentation analysis. The expression of cyclin A and B1 were determined by flow cytometry and Western blot. Annexin V assay was measured by flow cytometric analysis.
RESULTS:
PEP induced apoptosis and then inhibited cell proliferation in liver carcinoma cell line Bel-7402. Cells treated with PEP 50 mumol/L for 15 h were arrested in G2-phase with dramatical expression of cyclin A and a little change in cyclin B1. Almost all the apoptosis occurred in cells undergoing the G1-phase after treatment for 24 h.
CONCLUSION:
Peplomycin induced G1-phase specific apoptosis in Bel-7402 involving G2-phase arrest.
AuthorsHong-ying Chen, Cong-yi Zheng, Guo-lin Zou, Da-xing Xie, Jian-ping Gong
JournalActa pharmacologica Sinica (Acta Pharmacol Sin) Vol. 25 Issue 12 Pg. 1698-704 (Dec 2004) ISSN: 1671-4083 [Print] United States
PMID15569418 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibiotics, Antineoplastic
  • Cyclin A
  • Cyclin B
  • Peplomycin
Topics
  • Antibiotics, Antineoplastic (pharmacology)
  • Apoptosis (drug effects)
  • Carcinoma, Hepatocellular (metabolism, pathology)
  • Cell Line, Tumor
  • Cyclin A (metabolism)
  • Cyclin B (metabolism)
  • G1 Phase
  • G2 Phase
  • Humans
  • Liver Neoplasms (metabolism, pathology)
  • Peplomycin (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: